Search results
Phase Forward | 1756 obserwujących na LinkedIn. (Acquired by Oracle in 2010) | Phase Forward is a leading provider of integrated data collection and data management solutions for clinical...
16 kwi 2010 · Oracle announced today that it has agreed to acquire Phase Forward (NASDAQ: PFWD), a leading provider of applications for life sciences companies and healthcare providers, through a cash merger for $17.00 per share, or approximately $685 million.
17 kwi 2010 · BOSTON (Reuters) - Oracle Corp said on Friday it agreed to spend $685 million to buy Phase Forward Inc, the top maker of programs that help drugmakers run clinical trials, in Oracle's biggest...
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's technology and global services are designed to enable life sciences companies to automate and integrate the management of their entire clinical development process, from study initiation and FDA submission through.
19 sie 2010 · Oracle and Phase Forward executives offered their welcome as Phase Forward officially becomes part of the Oracle Health Sciences Global Business Unit.
16 kwi 2010 · Oracle paid $685 million to buy Phase Forward, a company that sells database applications to pharmaceutical companies and regulatory agencies. The deal is part of Oracle's strategy to enter the health care market and offer personalized medicine and value-based health care.
16 kwi 2010 · Latest solutions, case studies, interviews, practical articles for clinical trials operations, data management, technology, investigative sites and services.
